Sigma Genetics
YC W17Seattle, US · 2 employees · 2 known investors
Sigma Genetics makes devices that use magnetic fields to introduce DNA, RNA, and other charged molecules into cells, offering advantages over electroporation including reduced arcing, better scalability, and reduced invasiveness for in vivo applications. The technology targets cell therapies, cancer drug delivery, DNA vaccines, biopharmaceutical manufacturing, and cosmetics.
Founders & leadership· Y Combinator alumni (W17)
Investors · 2
Competitors · 7
by search overlapDiabetes Prevention Program8 shared keywords
BBB5 shared keywords
Macrogenics Inc5 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications. The company uses platform technologies such as antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Genomeweb5 shared keywordsGenomeWeb is a news and information publisher covering the molecular biology, genomics, and sequencing industry, reporting on business developments, research, and technology among life-science companies. Its content includes premium articles on commercial results, funding, and scientific developments for professionals in the genomics and diagnostics fields.
Sigma4 shared keywordsSIGMA supplies water and wastewater products including fittings, restraints, extended range products, municipal castings, fabrications, and custom parts for OEM manufacturers, serving customers across North America. The company also develops products such as coatings and linings and offers engineering and sourcing services for the water infrastructure market.
Mapquest4 shared keywordsProvider of geographical information systems and services; acquired by America Online.
Thumbnail for Seragon Pharmaceuticals4 shared keywords
Companies competing with Sigma Genetics for the same Google search keywords, organic and paid, via search-intersection analysis.